✦ LIBER ✦

ChlVPP/ABVVP, a first line ‘hybrid’ combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis

✍ Scribed by G. Martinelli; E. Cocorocchio; F. Peccatori; E. Zucca; P. C. Saletti; L. Calabrese; R. Pastano; G. Pruneri; C. Mazzetta; M. Ghielmini; F. Cavalli

Book ID: 108672651
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 131 KB
Volume: 125
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2004.04962.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide in combination as first-line c

Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A cancer and leukemia group B study

✍ Jeffrey J. Kirshner; James R. Anderson; Barbara Parker; Maurice Barcos; M. Rober 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 1 views

Background. In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease. Thirty-six evaluable patients were treated with two or three courses of methotrexate, vincristine, prednisone, leucovorin, etoposide, and cyclophos

Alternating ChlVPP/PAB1OE is better than

Alternating ChlVPP/PAB1OE is better than PAB1OE alone as initial chemotherapy for advanced Hodgkin's disease (HD): First results of a British National Lymphoma investigation (BNLI)/Central Lymphoma Group (CLG) study

✍ Hancock, B.W.; Cullen, M.H.; Vaughan Hudson, G. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Combination therapy with docetaxel and S

Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis

✍ Kazuaki Tanabe; Takahisa Suzuki; Noriaki Tokumoto; Hideki Yamamoto; Kazuhiro Yos 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 609 KB

Phase II trial of rituximab plus CVP com

Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study

✍ Hye Jin Kang; Won Seog Kim; Seok Jin Kim; Je-Jung Lee; Deok-Hwan Yang; Jin Seok 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 184 KB

Three-week combination chemotherapy with

Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients

✍ Koo, Dong Hoe; Ryu, Min-Hee; Ryoo, Baek-Yeol; Lee, Sung-Sook; Moon, Jung-Hwa; Ch 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 298 KB

Comparison between hybrid MOPPABV and AB

Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin’s lymphoma in public hospitals of the largest South American city—a retrospective 14-year study

✍ E. M. Souza; O. C. G. Baiocchi; M. A. Zanichelli; A. C. Alves; J. S. R. Oliveira 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 143 KB